 |
|
|
|
February 2000 Cover
|
|
Researchers have found that treating patients infected with HIV before complete seroconversion provides an opportunity to prevent irreversible immune damage.
The study suggests that 10 patients who were treated with hydroxyurea, didanosine, and indinavir during acute HIV infection before total seroconversion saw better
antibody response and T helper response.
Editor's Note: from Reuters Health Info Service
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
